Nektar Therapeutics Stock Forecast - Day Median Price

NKTR Stock  USD 1.19  0.02  1.71%   
Nektar Stock Forecast is based on your current time horizon. Although Nektar Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Nektar Therapeutics' systematic risk associated with finding meaningful patterns of Nektar Therapeutics fundamentals over time.
  
At this time, Nektar Therapeutics' Inventory Turnover is relatively stable compared to the past year. As of 01/07/2025, Payables Turnover is likely to grow to 4.73, while Fixed Asset Turnover is likely to drop 1.78. . As of 01/07/2025, Common Stock Shares Outstanding is likely to grow to about 229.4 M, though Net Loss is likely to grow to (314.8 M).
Nektar Therapeutics has current Day Median Price of 1.19. Median Price is the statistical median of an asset price for a given trading period.
Check Nektar Therapeutics VolatilityBacktest Nektar TherapeuticsInformation Ratio  

Nektar Therapeutics Trading Date Momentum

On January 07 2025 Nektar Therapeutics was traded for  1.19  at the closing time. The top price for the day was 1.25  and the lowest listed price was  1.14 . The trading volume for the day was 2.5 M. The trading history from January 7, 2025 did not cause price change. The trading delta at closing time against the current closing price is 1.68% .
The median price is the midpoint of the trading periods range.
Compare Nektar Therapeutics to competition

Other Forecasting Options for Nektar Therapeutics

For every potential investor in Nektar, whether a beginner or expert, Nektar Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Nektar Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Nektar. Basic forecasting techniques help filter out the noise by identifying Nektar Therapeutics' price trends.

Nektar Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Nektar Therapeutics stock to make a market-neutral strategy. Peer analysis of Nektar Therapeutics could also be used in its relative valuation, which is a method of valuing Nektar Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Nektar Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Nektar Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Nektar Therapeutics' current price.

Nektar Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Nektar Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Nektar Therapeutics shares will generate the highest return on investment. By undertsting and applying Nektar Therapeutics stock market strength indicators, traders can identify Nektar Therapeutics entry and exit signals to maximize returns.

Nektar Therapeutics Risk Indicators

The analysis of Nektar Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Nektar Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting nektar stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with Nektar Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Nektar Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nektar Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Nektar Stock

  0.84DNLI Denali Therapeutics Buyout TrendPairCorr
  0.63EVOK Evoke PharmaPairCorr
  0.81FOLD Amicus TherapeuticsPairCorr
  0.85JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr

Moving against Nektar Stock

  0.77LFCR Lifecore BiomedicalPairCorr
  0.66BMY Bristol Myers Squibb Aggressive PushPairCorr
  0.47GILD Gilead Sciences Sell-off TrendPairCorr
  0.4IMCC Im Cannabis CorpPairCorr
The ability to find closely correlated positions to Nektar Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Nektar Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Nektar Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Nektar Therapeutics to buy it.
The correlation of Nektar Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nektar Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nektar Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Nektar Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Nektar Stock Analysis

When running Nektar Therapeutics' price analysis, check to measure Nektar Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nektar Therapeutics is operating at the current time. Most of Nektar Therapeutics' value examination focuses on studying past and present price action to predict the probability of Nektar Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nektar Therapeutics' price. Additionally, you may evaluate how the addition of Nektar Therapeutics to your portfolios can decrease your overall portfolio volatility.